David Bruch

1.3k total citations
40 papers, 1000 citations indexed

About

David Bruch is a scholar working on Surgery, Molecular Biology and Pharmacology. According to data from OpenAlex, David Bruch has authored 40 papers receiving a total of 1000 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 12 papers in Molecular Biology and 8 papers in Pharmacology. Recurrent topics in David Bruch's work include Nitric Oxide and Endothelin Effects (5 papers), Coronary Interventions and Diagnostics (5 papers) and Organ Transplantation Techniques and Outcomes (5 papers). David Bruch is often cited by papers focused on Nitric Oxide and Endothelin Effects (5 papers), Coronary Interventions and Diagnostics (5 papers) and Organ Transplantation Techniques and Outcomes (5 papers). David Bruch collaborates with scholars based in United States and Thailand. David Bruch's co-authors include Dilip S. Kittur, Sudipta Tripathi, Chumpon Wilasrusmee, Smita Kittur, Skuntala Wilasrusmee, Kristopher G. Maier, Mark F. Fillinger, Emanuel R. Reinitz, Carl E. Bredenberg and Andrew M. Paskanik and has published in prestigious journals such as Neuroscience, Transplantation and Journal of Vascular Surgery.

In The Last Decade

David Bruch

37 papers receiving 945 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Bruch United States 15 214 204 184 178 136 40 1000
Michael Bulitta Germany 20 349 1.6× 50 0.2× 124 0.7× 157 0.9× 73 0.5× 28 1.1k
Jung Yeon Shim South Korea 22 170 0.8× 54 0.3× 329 1.8× 164 0.9× 71 0.5× 84 1.4k
Hossein Hosseini Iran 11 104 0.5× 60 0.3× 128 0.7× 114 0.6× 109 0.8× 54 659
Nam Ho Kim South Korea 21 213 1.0× 48 0.2× 166 0.9× 374 2.1× 27 0.2× 125 1.4k
Nevin Uzuner Türkiye 18 137 0.6× 55 0.3× 326 1.8× 130 0.7× 61 0.4× 124 994
Ana Rosa Rincón‐Sánchez Mexico 20 149 0.7× 134 0.7× 61 0.3× 259 1.5× 28 0.2× 57 1.2k
Adam Białas Poland 21 359 1.7× 61 0.3× 323 1.8× 290 1.6× 113 0.8× 97 1.4k
Fernanda Degobbi Tenório Quirino dos Santos Lopes Brazil 25 101 0.5× 35 0.2× 612 3.3× 254 1.4× 86 0.6× 65 1.4k
A Ledda Italy 25 260 1.2× 42 0.2× 56 0.3× 391 2.2× 113 0.8× 93 1.7k

Countries citing papers authored by David Bruch

Since Specialization
Citations

This map shows the geographic impact of David Bruch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Bruch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Bruch more than expected).

Fields of papers citing papers by David Bruch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Bruch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Bruch. The network helps show where David Bruch may publish in the future.

Co-authorship network of co-authors of David Bruch

This figure shows the co-authorship network connecting the top 25 collaborators of David Bruch. A scholar is included among the top collaborators of David Bruch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Bruch. David Bruch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bruch, David, et al.. (2019). Practicing metacognition through the use of repeated posttest predictions. Currents in Pharmacy Teaching and Learning. 11(6). 630–634. 6 indexed citations
2.
Bruch, David, et al.. (2016). Fluvastatin inhibits intimal hyperplasia in wild-type but not Thbs1 -null mice. Journal of Surgical Research. 210. 1–7. 6 indexed citations
3.
Tripathi, Sudipta, David Bruch, & Dilip S. Kittur. (2008). Ginger extract inhibits LPS induced macrophage activation and function. BMC Complementary and Alternative Medicine. 8(1). 1–1. 220 indexed citations
4.
Tripathi, Sudipta, David Bruch, Louis A. Gatto, & Dilip S. Kittur. (2008). Green Tea Extract Prolongs Allograft Survival as an Adjunctive Therapy Along With Low Dose Cyclosporine A. Journal of Surgical Research. 154(1). 85–90. 7 indexed citations
5.
LaSpina, Mark, Sudipta Tripathi, Louis A. Gatto, et al.. (2008). An Interleukin-6-Neutralizing Antibody Prevents Cyclosporine-Induced Nephrotoxicity in Mice. Journal of Surgical Research. 148(2). 121–125. 18 indexed citations
6.
Shah, Gaurang, Frank A. Middleton, Karen Gentile, et al.. (2008). Cyclosporine Inhibition of Angiogenesis Involves the Transcription Factor HESR1. Journal of Surgical Research. 149(2). 171–176. 9 indexed citations
7.
Tripathi, Sudipta, Kristopher G. Maier, David Bruch, & Dilip S. Kittur. (2007). Effect of 6-Gingerol on Pro-Inflammatory Cytokine Production and Costimulatory Molecule Expression in Murine Peritoneal Macrophages. Journal of Surgical Research. 138(2). 209–213. 117 indexed citations
8.
Dong, Feng, et al.. (2007). Selective inhibition of cyclooxygenase-2 exacerbates methamphetamine-induced dopamine depletion in the striatum in rats. Neuroscience. 150(4). 950–958. 21 indexed citations
9.
Wilasrusmee, Chumpon, et al.. (2004). Signal Transduction Pathway in Endothelial Dysfunction. Surgical Infections. 5(1). 9–14. 4 indexed citations
10.
Shah, Gaurang, et al.. (2004). Cross‐species comparison of gene expression between human and porcine tissue, using single microarray platform – preliminary results. Clinical Transplantation. 18(s12). 76–80. 30 indexed citations
11.
Wilasrusmee, Chumpon, et al.. (2003). β1-integrin—ligand disengagement induces in vitro capillary tube disruption mediated by p38 MAPK activity. Surgery. 134(2). 164–168. 2 indexed citations
12.
Wilasrusmee, Chumpon, Bhupinder Singh, David Bruch, et al.. (2003). Morphological and biochemical effects of immunosuppressive drugs in a capillary tube assay for endothelial dysfunction. Clinical Transplantation. 17(s9). 6–12. 41 indexed citations
13.
Shah, Gaurang, Chumpon Wilasrusmee, Arthur H. Tatum, et al.. (2003). Role of ve-cadherins, beta-1 integrins and endothelin-1 in endothelial dysfunction after cardiac transplantation. Journal of Surgical Research. 114(2). 255–256. 7 indexed citations
14.
Wilasrusmee, Chumpon, David Bruch, Gaurang Shah, et al.. (2003). Amelioration of cyclosporin A effect on microvasculature by endothelin inhibitor. Surgery. 134(2). 384–389. 13 indexed citations
15.
Wilasrusmee, Chumpon, et al.. (2002). In Vitro Immunomodulatory Effects of Ten Commonly Used Herbs on Murine Lymphocytes. The Journal of Alternative and Complementary Medicine. 8(4). 467–475. 63 indexed citations
16.
Wilasrusmee, Chumpon, Bhupinder Singh, Smita Kittur, et al.. (2002). A New in Vitro Model to Study Endothelial Injury. Journal of Surgical Research. 104(2). 131–136. 18 indexed citations
17.
Squiers, Elizabeth C., et al.. (1999). Pretreatment of small bowel isograft donors with cobalt-protoporphyrin decreases preservation injury. Transplantation Proceedings. 31(1-2). 585–586. 26 indexed citations
19.
Bruch, David, et al.. (1998). Graft survival and MLC response in LEW-ACI small bowel transplants treated with a novel MHC peptide, BC-1nl. Transplantation Proceedings. 30(6). 2590–2591. 2 indexed citations
20.
Fillinger, Mark F., et al.. (1990). Does the end-to-end venous anastomosis offer a functional advantage over the end-to-side venous anastomosis in high-output arteriovenous grafts?. Journal of Vascular Surgery. 12(6). 676–690. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026